SCHEMBL27632107

SCHEMBL27632107

Fc1cc(CCBr)ccn1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 4/20 0.59
KCNQ2 O43526 1/20 0.41
CYP3A4 P08684 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
ADRA1D P25100 1/20 0.41
ADRA1A P35348 1/20 0.41
ADRA1B P35368 1/20 0.41
KCNH2 Q12809 1/20 0.41
KCNH3 Q9ULD8 6/20 0.40
TDP1 Q9NUW8 1/20 0.38
FFAR1 O14842 1/20 0.36
NR3C2 P08235 3/20 0.34
IDO1 P14902 1/20 0.33
LOX P28300 2/20 0.32
RECQL P46063 1/20 0.31
NOS3 P29474 1/20 0.31
NOS1 P29475 1/20 0.31
NOS2 P35228 1/20 0.31
LOXL3 P58215 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12553823 0.83
SCHEMBL501592 0.83
SCHEMBL29893902 0.83
Hydrochloric Acid SCHEMBL2965940 0.81 LOXL2 (0.61) LOXL2KCNQ2CYP3A4ALOX15TSHR
SCHEMBL1211358 0.79 LOXL2 (0.59) LOXL2KCNQ2CYP3A4ALOX15TSHR
SCHEMBL1029000 0.79 LOXL2 (0.70) LOXL2KCNQ2CYP3A4ALOX15TSHR
SCHEMBL10238963 0.79 LOXL2 (0.59) LOXL2KCNQ2CYP3A4ALOX15TSHR
SCHEMBL8493165 0.78 LOXL2 (0.57) LOXL2KCNQ2CYP3A4ALOX15TSHR
SCHEMBL30527951 0.77 TDP1 (0.39) LOXL2TDP1NR3C2IDO1LOX
SCHEMBL17242282 0.77 TDP1 (0.39) LOXL2TDP1NR3C2IDO1LOX

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101495461-A Novel HIV reverse transcriptase inhibitors GILEAD SCIENCES INC (US) 2009-07-29 CN disclosed
CN-1768054-A Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors AVENTIS PHARMA SA (FR) 2006-05-03 CN disclosed